Children’s Hospital GME Support Reauthorization Act of 2025

This bill extends federal payments to children’s hospitals that run medical residency programs through 2030 and sets yearly funding for two parts of the program at $124 million and $261 million for 2026–2030.

Starting in fiscal year 2026, a children’s hospital will lose these payments if it provided certain surgeries or medications to anyone under 18 during the prior year. For 2026, the rule applies to payments after December 31, 2025, and looks back to care given between September 1 and December 31, 2025. The “specified procedures and drugs” include surgeries like mastectomy, vaginoplasty, phalloplasty, and other operations to change sex characteristics, and medications such as puberty blockers and cross-sex hormones. Exceptions include treatment for precocious puberty, certain intersex conditions, complications from prior procedures, or urgent care needed to prevent death or serious harm for reasons other than changing sex characteristics. The bill defines “sex” by biological traits present at birth. It also makes clear that hospitals can still receive payments if they provide mental or behavioral health care for gender dysphoria that does not include the specified procedures or drugs .

• Who is affected: Children’s hospitals with residency programs; patients under 18 and their families.
• What changes: Funding is extended and set for 2026–2030; hospitals that provide listed procedures or drugs to minors cannot receive these payments, with specific medical exceptions and a mental health carve‑out .
• When: Funding levels apply 2026–2030; the payment ban begins for payments after December 31, 2025, based on services provided Sept 1–Dec 31, 2025, and then on the prior fiscal year after that.